MetaCap

DarioHealth (DRIO) vs Microbot Medical (MBOT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Summary

DarioHealth (DRIO) has outperformed Microbot Medical (MBOT) over the past year, losing 63.0% versus a loss of 67.5%. Over five years, MBOT leads with a -85.1% price change compared with -98.2% for DRIO. Microbot Medical is the larger company by market cap ($71.9 million vs $56.8 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DRIO-65.39%MBOT-66.25%
+7%-32%-70%
Oct 9, 20251 yearOct 8, 2026
DRIO-97.73%MBOT-85.08%
+54%-26%-105%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DRIO versus MBOT key metrics
MetricDRIOMBOT
Share price$5.80$1.07
Market cap$56.84M$71.87M
1-day change+4.69%0.00%
YTD return-49.03%-46.50%
1-year return-63.03%-67.48%
5-year return-98.21%-85.08%
EPS (TTM)$-2.39$-0.25
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$16.50$3.04
52-week low$5.37$1.05
Distance from 52-week high-64.85%-64.80%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+134.48%+491.59%
Average volume25.33K653.62K
Shares outstanding9.80M67.16M
Employees16043
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About DarioHealth

DRIO stock →

DarioHealth Corp. operates as a digital health company in the United States and internationally.

Health Care · Medical/Dental Instruments · 160 employees

About Microbot Medical

MBOT stock →

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.

Health Care · Medical/Dental Instruments · 43 employees

DRIO vs MBOT FAQ

Which is bigger, DarioHealth or Microbot Medical?

Microbot Medical (MBOT) is larger, with a market capitalization of $71.87M compared with $56.84M for DarioHealth (DRIO).

Which stock has performed better over the past year, DRIO or MBOT?

DRIO returned -63.03% over the past 12 months, compared with -67.48% for MBOT (price return, excluding dividends). Past performance does not predict future results.

Are DarioHealth and Microbot Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons